Market News
Market news
-
News AGC Biologics to increase capacity for pDNA and mRNA manufacturing in Heidelberg
The expansion plans include an additional manufacturing line, a new cleanroom and a new process development lab -
News Room for specialists and one-stop-shops in CDMO space
As CDMOs seek to diversify their business models, is a full-service offering the holy grail or is there a danger of biopharmaceutical outsourcing firms becoming the jack of all trades and the master of none? -
News Recro and BioCorRx expand partnership for OUD treatment
The CDMO, through its recent acquisition of IsiSys, will help to advance BICX104 toward first-in-human clinical trials -
News Olon to combine protein production expansion with sustainability
The new area will produce proteins using innovative and highly sustainable processes such as microbial fermentation -
News Thermo Fisher to build facility in Nashville for production of single-use technologies products
Investment will further expand CDMO's global network of SUT facilities to boost reliable supply of critical materials used to produce new biologics and vaccines -
News Emerging regional markets show promise as CDMO globalisation trend grows
Opportunities for CDMO expansion are extending to Latin America and Africa, say experts -
News GenScript ProBio to manufacture clinical trial batches of Synimmune's lead antibody drug
The CDMO will manufacture drug substance and drug product for Phase II clinical trials in AML patients -
News Takeda to supply Japan with 150 million doses of Novavax COVID vaccine
Japan's biggest drugmaker prepares to make the vaccine domestically and anticipates early 2022 distribution -
News Formulated Solutions completes investment and expansion project
The CDMO significantly increases its footprint, capacity and capabilities to meet current and future demand -
News 3i Group backs ten23 health to create global CDMO focused on biopharma injectables
The new Switzerland-based CDMO differentiates itself by its sustainable vision of making a positive impact for people and planet -
News Reopened USAntibiotics penicillin facility to relieve US dependence on Chinese antibiotics: Jackson Healthcare
The facility will be able to manufacture and stockpile a five-year supply of amoxicillin for the US -
News Cipla and Kemwell to form joint venture targeting respiratory biosimilars market
The agreement is expected to accelerate Cipla’s global lung leadership agenda -
News Medicines Manufacturing Innovation Centre aims to 'solve major pharma industry challenges'
£35 million public-private collaboration to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain -
News Recipharm expands its analytical services offering in India
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions -
News Signature Biologics opens additional manufacturing and R&D facility
The new facility will augment the company's capacity to broaden its portfolio of perinatal-derived products -
News Lonza to establish multi-product fill and finish line in China
The new production line at Guangzhou site will supply global and domestic companies with clinical and commercial batches -
News Curia lays out plans to expand complex API manufacturing capacity
The $35 million investment will more than double the site’s batch-size scaling and product output. -
News Biotage expands production capacity to ease lipid bottlenecks
New site in Cardiff boosts the company's production capacity for equipment crucial in the supply chain for mRNA vaccines production -
News Tikun Olam-Cannbit and Wavelength strike novel cannabis agreement
Firms say the partnership will "multiply the power of both companies, the pharmaceutical industry and the medical cannabis industry" -
News Recro eyes expansion to full-service CDMO status
The solid oral dose specialist signs letter of intent for acquisition of a CDMO providing a full range of services -
News Moderna to build mRNA vaccine manufacturing facility in Canada
The new facility will provide access to domestically manufactured vaccines against respiratory viruses -
News 5 Things We Learned from the CPHI North America Content Program
The CPHI North America exhibition is taking place in-person this week in Philadelphia from 10-12 August. Here we take a look at key learnings from the past two weeks of expert-led content, available to all attendees as part of the hybrid event experien... -
News Bora Pharmaceuticals and KYOWA agree generic manufacturing contract
KYOWA Pharmaceutical Industry will be the CDMO's first Japanese client for its Zhunan manufacturing site -
News Heraeus completes additional production line for platinum-based HPAPIs
The expansion is Heraeus’ response to increasing global demand for these products in cancer treatment -
News Cosmetics packaging needs to respond to increasing consumer awareness of sustainability: CPHI Webinar panel
The cosmetics packaging sector will need to respond to increasing consumer awareness of climate change by transitioning from fossil-based materials to long-term carbon neutral and carbon negative alternatives, according to industry experts speaking at ... -
News Tech transfer: a many-layered artform that demands precision and communication
Tech transfer is a crucial phase that converts clinical promise into commercial gain but pressure on sponsors to reduce time to market in the age of COVID-19 means CDMOs have to be on top of their game to deliver. What are the latest innovations to sol... -
News DisperSol signs up Catalent for manufacturing of multiple pharma products
The collaboration will see Catalent install a commercial-scale KinetiSol technology manufacturing line at its Somerset, New Jersey, facility -
News WuXi STA completes acquisition of its first European facility
The purchase of BMS's Couvet, Switzerland facility adds commercial-scale production capacity for capsule and tablet dosage forms -
News Viatris and Biocon score historic first for interchangeable biosimilar product
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US -
News Diversification and addition of capabilities key to CDMO success as end markets grow: CPHI North America panel
CDMOs need to diversify and expand their capabilities to take full advantage of strong growth in prominent end markets such as small molecule, monoclonal antibodies and cell and gene therapy, according to an industry expert on a panel at the CPHI North... -
News Sartorius extends its cell culture media business via acquisition
Acquiring Xell AG will enable Sartorius to offer specialised media for manufacturing viral vectors -
News Thermo Fisher pledges to reach carbon neutrality by 2050
Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change -
News Abzena and BioXpress Therapeutics partner to provide global biosimilar support
The combined capabilities will offer flexibility and innovation from small-scale biosimilar development through to large-scale manufacturing -
News Merck KGaA invests €270 million to create "site of the future"
The investment will fund the construction of a Translational Science Center for its Healthcare business sector, as well as a new Learning Center -
News BioNTech to purchase Kite manufacturing facility and cell therapy R&D platform
The acquisition will add manufacturing footprint in the US enabling the company to develop its pipeline of novel cancer product candidates -
News Samsung Biologics and Kineta strike cancer immunotherapy development and manufacturing deal
Samsung to provide end-to-end CDMO services to advance Kineta's novel anti-VISTA antibody for the treatment of solid tumours -
News Skyepharma selects Veratrak platform to ensure secure data storing and sharing
Using Veratrak's platform, the CDMO will have full oversight of data, including an audit trail of data and document processes -
News Curia to buy fellow CDMO Integrity Bio
Acquisition will add West Coast coverage to the CDMO's East Coast and European capabilities and enhance its biologics formulation development and fill-finish network -
News Catalent enters CBD anaesthetic product formulation project
The company will use its orally disintegrating tablet technology Zydis for JOS Pharmaceuticals' licensed CBD product -
News Sparx Therapeutics to build first commercial antibody drug production facility in China
The emerging biotech company unveils plans for a 1.2 million-sq. ft manufacturing facility in Yangzhou -
News Sinovac Biotech signs up to supply COVAX with CoronaVac
China-based company could supply up to 380 million doses from July 2021 through to June 2022 -
News LGM Pharma launches analytical and stability testing as standalone service
The integrated CDMO rolls out services to the broader community of drug manufacturers and developers -
News Thermo Fisher supports gene developers with new AAV manufacturing solutions
A new media panel, gene kit and advanced resins help reduce manufacturing costs and increase the viability of gene therapies -
News Almac's Charnwood site achieves H&S and environmental certification
The CDMO plans to roll out the ISO 45001 and ISO 14001 certification throughout multiple sites worldwide -
News Novartis shifts Leqvio manufacturing to Austrian facility
Pharma firm tells FDA tech transfer to its own facility in Schaftenau, Austria is underway after regulator highlighted concerns about third party CDMO site in Italy -
News Recipharm selected to operate new fill/finish facility in Morocco
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country -
News Second Curaleaf GMP cannabis facility gains Spanish approval
Medalchemy facility now fully licensed to import, cultivate, extract, manufacture and export medical cannabis flower and extracts -
News Viralgen opens expanded AAV manufacturing facility in Spain
The CDMO's fivefold capacity increase will provide early preclinical through to commercialisation support -
News Amgen to build new assembly and final packaging facility in Ohio
Greenfield construction of the new facility is expected to start later this year -
News Sanofi to accelerate mRNA vaccines through new Center of Excellence
The company will invest €400 million per year to advance mRNA technology beyond the pandemic -
News Lonza to invest in mid-scale API manufacturing expansion at Chinese facility
The expansion of mid-scale capacity will enable the company to offer a smooth transition between early-phase and large-scale commercial production -
News CPHI Podcast Series: M&A strategies in the CDMO sector
This month we discuss what is driving M&A strategies in the pharma space, paying particular attention to how investors regard the potential for the growing but fragmented CDMO sector -
News Genezen begins construction of cGMP lentiviral production facility
The investment will provide capacity to support current and future demands for the rapidly evolving cell and gene therapy sector -
News CPHI Webinar: Trends and Advances in Patient Centric Drug Development - Watch On Demand
Catch up on the latest trends and developments in patient centric drug development -
News Vectura to provide preclinical support for Incannex's inhaled brain injury treatment
IHL-216A may make sports safer and reduce the morbidity and mortality rates of people suffering serious head traumas -
News ProBioGen and LAVA Therapeutics sign cell line development agreement
The agreement marks the second cell line development collaboration between the two companies -
News Coriolis Pharma expands facilities for ATMP development
The expansion close to company's Martinsried headquarters includes a lyophilisation development centre for advanced therapy medicinal products -
News Pandemic creates extra demand for CDMO services but investment decisions remain key to success
While the COVID-19 pandemic has created even greater demand for partnerships, CDMOs need to be aware that the needle has shifted, creating both opportunities and challenges and changing how the services industry does business -
News Bayer makes €250 million manufacturing investment in Finland
The company expects to complete its building and modernising plans in Turku by 2025 -
News Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch
Drug categories impacted by travel restrictions expected to see higher sales levels in FY22 -
News Construction underway for Yposkesi's second commercial bioproduction site
The French CDMO is also creating a new global resource for drug developers of ATMPs -
News WuXi XDC and LegoChem sign MoD to make more ADCs accessible to patients
XDC will provide a full range of development and manufacturing services in one centralised region -
News Entegris to expand three life sciences manufacturing facilities
The expanded capacity and capabilities include the development of a dedicated Life Sciences Technology Center -
News EmpowerPharm certified to manufacture CBD products to prescription drug standards in Canadian first
New $30 million manufacturing facility in Burlington, Ontario, will allow company to manage R&D in-house and scale production without reliance on third-party manufacturers -
News Pharma supply chain companies form alliance to accelerate sustainability
Alliance to Zero aims to facilitate the transition of the pharma sector to reach net zero emissions target -
News Siegfried starts to ramp up production after cyber attack
Hameln plant which provides fill and finish for Pfizer-BioNTech COVID-19 shot should be fully operational within the week, CDMO says -
News Samsung Biologics expands portfolio with mRNA vaccine manufacturing capability
The additional manufacturing suite at the CDMO's Songdo site is anticipated to be ready for cGMP operations within the first half of 2022 -
News MedPharm expands topical and transdermal delivery services
A new location in Raleigh-Durham, North Carolina, close to the CDMO's Center of Excellence, will double its current footprint -
News Bacthera secures double nod to tread on "virgin territory"
The specialist CDMO receives manufacturing licenses from Switzerland and Denmark to supply customers with live biotherapeutic medicines -
News Cambrex completes GMP manufacturing expansion in Estonia
The expansion will accelerate the progression and tech transfer of projects within the early clinical development phases -
News Sharp makes land acquisition to expand cGMP packaging capacity
The purchase is part of $17 million capacity expansion, which is in addition to a wider $43 million investment into the company's Pennsylvania operations -
News Samsung Biologics to provide fill-finish manufacturing for Moderna COVID vaccine
The CDMO will support the production of hundreds of millions of doses from its facility in Incheon, South Korea. -
News ‘Conscious consumer’ demand is propelling cosmeceuticals industry, experts tell CPHI Discover audience
Upstream raw materials suppliers seen as the main source of innovation in a growing industry driven by demand for more natural ingredients manufactured in clean, sustainable way -
News Innovating in the viscosity design space with a new 2.25 mL autoinjector platform
Extending its patient-centric BD Intevia™ Disposable Autoinjector platform, BD builds on past successes while meeting the requirements of new, highly viscous, high-volume biologics for chronic diseases -
News Sandoz outlines European antibiotic manufacturing expansion
Novartis generics and biosimilars division will invest €150 million during the next 3-5 years at its Kundl, Austria and Palafolls, Spain sites while phasing out production of oral APIs at Les Franqueses site -
News Brexit impact on UK pharma industry a moveable feast, industry experts tell CPHI Discover
The UK’s withdrawal from the European Union has meant the pharmaceutical industry has had to adapt to some monumental changes in terms of research, regulatory affairs, and trade. In this CPHI Webinar, three industry experts discussed what the fut... -
News Europe approves SK Bioscience’s global COVID-19 vaccine plant
CDMO's site becomes the first vaccine production facility in South Korea to obtain EU GMP certification, allowing it to ship to Europe -
News Novasep to expand HPAPI manufacturing capacity to keep pace with demand
The plan includes the creation of more than 30 full-time jobs at the CDMO's Le Mans site -
News Sterling Pharma Solutions signs up to manufacture OncoTEX's ovarian cancer drug
The CDMO's expertise and capabilities a "perfect fit" for overcoming the challenges of manufacturing this complex molecule -
News Catalent buys Belgian CDMO to boost pDNA manufacturing and service offering
New facility at Gosselies site will host commercial scale pDNA manufacturing as Catalent extends its cell and gene therapy footprint -
News CPHI Discover: Earlier partnerships between pharma and excipient manufacturers are the key to success
In the future pharma companies will need to work closer with excipient companies if we are to develop better formulations more quickly -
News Richter-Helm invests €70M to triple its production capacity in Germany
The addition of two new manufacturing trains will support the demand for high-value biopharmaceutical products -
News Ex-Legacy Pharmaceuticals machinery and equipment up for sale, says Hilco Industrial
Industrial assets purchaser is offering high-capacity production line equipment formerly owned by bankrupt CMO -
News Moderna to transform Massachusetts site into industrial technology centre
The expansion will support a 50% increase in production of biotech's COVID-19 vaccine at its manufacturing site -
News N-SIDE launches Production App to optimise clinical manufacturing process
The software consulting company claims its software solution has already saved one pharma company €10.5 million -
News Moderna signs agreement with Gavi to supply COVID-19 vaccine
Biotech ties up deal three days after World Health Organization issued an emergency use listing for the mRNA vaccine -
News Alibaba bans online listing and trade of pharmaceutical products
Sweeping ban includes APIs, intermediates and prescription and OTC medicines and comes amid tight regulatory requirements and the "high risk nature" of pharma products, e-commerce giant says -
News Bushu and Suzuken team up to support manufacturers eyeing up Japanese market
The new business alliance will support new product launches for specialty pharmaceutical manufacturers looking to enter the Japanese market -
News Sanofi to provide fill and finish manufacturing support for Moderna vaccine
French company is now providing manufacturing capacity to support three different COVID-19 vaccines -
News Lonza to build small molecule manufacturing complex at Visp site
CHF 200 million investment will include dedicated line for antibody-drug conjugate payload molecules and is scheduled to start operations in Q3 2023 -
News FDA inspection report slams Emergent for quality and cleanliness breaches at Bayview facility
Company failed to investigate vaccine drug substance discrepancies thoroughly, says US regulator -
News Bharat Biotech scales up Covaxin manufacturing capacity in India
The company will expand multiple facilities in Hyderabad and Bangalore to help reach its target of approximately 700 million doses per year of the COVID-19 vaccine -
News AGC Biologics and Rocket Pharma expand LVV manufacturing partnership
The expanded agreement will ensure Rocket Pharma's supply of lentiviral vectors across its pipeline -
News EU secures additional 100 million doses of Pfizer-BioNTech vaccine for 2021 delivery
Extra supply will bring total number of doses scheduled to be shipped to EU this year to 600 million -
News Sartorius expands manufacturing capacities in China and the UK
The expansions will enable the company's local customers to test equipment directly at the manufacturing site -
News CPHI Japan open for business!
Informa Markets' first in-person trade show of the year welcomes attendees in Tokyo as face-to-face interaction recommences among pharma community -
News Lonza and Junshi Biosciences expand biologics manufacturing collaboration
The antibody-based products will be expressed using Lonza's GS Xceed Gene Expression System -
News KD Pharma acquires Switzerland-based cannabinoid manufacturer PhytoXtract
The global CMO plans to have a complete, licensed cGMP manufacturing facility online by the end of 2021 -
News Catalent boosts plasmid DNA manufacturing at Rockville with addition of ABEC fermenters
The company's custom single run single-use fermenters supplied on fast-track schedule to support flexible manufacturing of plasmid DNA -
News Bavarian Nordic receives $28 million Ebola vaccine order from J&J
The smallpox vaccine specialist will manufacture and deliver bulk drug substance of MVA-BN Filo vaccine during the second half of this year -
News Moderna and Catalent expand COVID vaccine manufacturing agreement
The extended collaboration comes after reaching the initial milestone of producing 100 million doses -
News Sterling Pharma seals acquisition of bioconjugation specialist ADC
By integrating its HPAPI capabilities with those at ADC Biotechnologies' Deeside facility, small molecule CDMO will be able to offer the development and manufacturing of toxin linkers -
News NextPharma completes purchase of Lonza lipid oral dosage form manufacturing sites
Ploermel and Edinburgh facilities employ around 390 permanent staff and will allow UK CDMO to expand its technology offering -
News TCR2 bets on lead candidate with new cell therapy manufacturing facility
The US facility in Rockville is expected to accelerate the company’s commercial-scale manufacturing timelines of gavo-cel -
News Lonza to support Pionyr Immunotherapeutics' oncology drug development
The CDMO will provide cell line development, process development, drug substance and drug product manufacturing for Pionyr’s monoclonal antibody candidate -
News KD Pharma expands CDMO capabilities via asset acquisition
The former Rohner's manufacturing assets will enable omega-3 heavyweight to manufacture difficult, multi-step pharmaceutical intermediates and APIs -
News GSK to manufacture 60 million doses of Novavax vaccine for the UK
Pharma company will provide fill and finish manufacturing capacity at its Barnard Castle facility as early as the beginning of May 2021 -
News Nutrition additive supply chains 'nervous' as Suez blockage continues
Some seaborne deliveries are being rerouted or switched to air transportation as efforts to re-float stricken Ever Given container vessel move into fourth day -
News CURE Pharmaceutical gains DEA go-ahead to research psychedelics compounds
Company will use extension of Schedule I licence to start development of psychedelics-based pipeline to treat mental health disorders -
News China's Raybow Pharmaceuticals invests $15.8 million to expand US facility
The company will triple its capacity and workforce at its North Carolina site to increase its global capabilities and reach -
News Catalent signs ODT technology development agreement with Cybin
The CDMO's Zydis technology will help the Canadian biotech to develop fast-acting, shorter-duration formulations of its potential therapy for treatment-resistant psychiatric disorders -
News Wuxi Vaccines' Ireland site still on course for 2022 despite COVID challenges
Despite COVID-related challenges and supply chain issues, the CDMO's $240 million new facility is on target to open next year -
News PCI Pharma Services expands Berlin cold chain clinical supply storage capabilities
The move ensures the service provider has the capacity to meet the needs of an evolving clinical market -
News Growing drug delivery CDMO Kindeva expands UK operations
US-headquartered company Kindeva seals deal for an R&D facility at Loughborough’s life sciences hub -
News European countries suspend use of AstraZeneca COVID-19 vaccine as regulators investigate blood clot reports
Regulators stress temporary halt is precautionary measure and that there is currently no evidence linking the shot to adverse events -
News Growth opportunities abound for auto-injectors amid patient-centric healthcare transition, experts tell CPHI webinar
Tremendous growth opportunities exist for auto-injectors as their value is increasingly being recognised across several therapy areas, experts have told a recent CPHI webinar, sponsored by Stevanato Group. -
News ANI Pharmaceuticals expands CDMO business through Novitium acquisition
The purchase will allow the company to add nine new customers to its growing CDMO business and 27 manufacturing suites -
News Inhalation specialist Vectura invests to expand manufacturing capabilities
The enhancements will include installing the lever-operated multi-dose inhaler device used in Hikma’s generic Advair product, which the FDA recently approved -
News CPHI post-pandemic report forecasts explosion of contract services growth
During the next 12 months, demand for early-stage contract projects could quickly exceed supply -
News Lonza to develop and manufacture Ixogen's oncolytic virus
PsiVac has generated compelling efficacy data in killing a broad range of tumour cells, including head and neck, bladder, liver, pancreatic and ovarian
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance